Hospices Civils De Lyon

Oncology and rare cancers

Clinical research covers advanced and metastatic solid tumours, with particular attention to mesothelioma, gastric adenocarcinoma, ovarian cancer, neuroendocrine carcinoma, thymic malignancies, anaplastic thyroid carcinoma, and gestational trophoblastic neoplasia. The portfolio also includes studies in metastatic prostate cancer and other treatment-resistant cancers.

  • Malignant pleural and peritoneal mesothelioma
  • Advanced gastric cancer
  • Rare thoracic and endocrine tumours
  • Gastro-enteropancreatic neuroendocrine neoplasms

Research interest extends to immunotherapy, targeted cancer treatment, and surgical or locoregional management in advanced disease.

Neurology, neuroimaging, and movement disorders

Trials address Parkinson disease, Tourette disorder, epilepsy, cluster headache, stroke, intracerebral haemorrhage, transient ischemic attack, and broader nervous system diseases. Several studies focus on brain receptor pathways, functional connectivity, and inflammatory imaging markers.

  • Parkinson disease
  • Epilepsy and seizure disorders
  • Tourette disorder
  • Stroke and cerebrovascular disease

There is also interest in PET-MRI, serotonergic pathways, and adrenergic receptor biology.

Pulmonary, critical care, and infectious disease

The sponsor funds studies in asthma, idiopathic pulmonary fibrosis, ventilator-acquired pneumonia, and septic shock. Research also includes inflammatory and immune-related respiratory conditions such as extra-pulmonary sarcoidosis.

  • Asthma
  • Idiopathic pulmonary fibrosis
  • Ventilator-acquired pneumonia
  • Septic shock

Additional work explores immune modulation in acute infection and respiratory failure.

Autoimmune, transplant, and haematology

Clinical activity includes systemic lupus erythematosus, ANCA-associated vasculitis, granulomatosis with polyangiitis, microscopic polyangiitis, renal transplantation, and allogeneic haematopoietic stem cell transplantation. These studies reflect interest in immune-mediated disease, graft outcomes, and transplant-related immunosuppression.

  • Systemic lupus erythematosus
  • ANCA-associated vasculitis
  • Kidney transplantation
  • Haematopoietic stem cell transplantation

Research also touches on graft rejection and immune recovery after transplantation.

Dermatology, ophthalmology, and paediatric care

Further trials involve Stevens-Johnson syndrome, toxic epidermal necrolysis, bilateral limbal stem cell deficiency, diabetic macular oedema, and cerebral palsy with pathological drooling. The portfolio also includes obesity in children and adolescents, postoperative pain, and drug dependence.

  • Severe bullous skin reactions
  • Limbal stem cell deficiency
  • Diabetic macular oedema
  • Paediatric neurological and functional disorders

These studies span skin regeneration, vision-threatening disease, and supportive care in paediatrics.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Spironolactone for Patients with Arrhythmogenic Right Ventricular Dysplasia (ARVD)

    Not yet recruiting

    2 1 1
    Investigated drugs:
    France
  • Study on the Expression of the 5-HT4 Receptor in Patients with Mild to Moderate Parkinson’s Disease Using [C11]-SB207145

    Not recruiting

    4 1 1
    Investigated diseases:
    France
  • Study on the Effectiveness of Nintedanib for Treating Nosebleeds in Patients with Hereditary Hemorrhagic Telangiectasia

    Not recruiting

    2 1 1
    Investigated drugs:
    France
  • Study on Botulinum Toxin A and Hyoscine for Treating Drooling in Children Over 4 with Cerebral Palsy

    Not recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Study on Talazoparib for Maintenance Treatment in Patients with Advanced Malignant Pleural or Peritoneal Mesothelioma After Initial Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated drugs:
    France
  • Study on Idiopathic Pulmonary Fibrosis: Evaluating Pirfenidone and Nintedanib for Patients with Progressive Disease

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France